Nebivolol Sandoz Ltd

Nebivolol, the active ingredient in Nebivolol Sandoz Ltd, is a beta blocker presented as a tablet for oral use. It selectively blocks β1‑adrenergic receptors and enhances nitric‑oxide release, helping to lower high blood pressure in adult patients.

GNH USA supplies Nebivolol Sandoz Ltd as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Nebivolol is a selective β1‑adrenergic antagonist used in the management of cardiovascular conditions that involve elevated vascular resistance.

- Hypertension: reduces systolic and diastolic blood pressure in patients with essential hypertension. - Heart failure with reduced ejection fraction: improves cardiac output and may reduce hospitalization risk. - Left ventricular dysfunction: supports ventricular remodeling by lowering afterload.

Nebivolol may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Headache: mild to moderate intensity. - Dizziness or light‑headedness, especially after standing. - Fatigue or general tiredness. - Nausea or mild gastrointestinal upset. - Bradycardia: slower than normal heart rate. - Insomnia or sleep disturbances.

Serious or Rare Side Effects: - Severe bradycardia or heart block requiring medical attention. - Marked hypotension leading to fainting. - Allergic reactions such as rash, pruritus, or angioedema. - Hepatic dysfunction or elevated liver enzymes. - Worsening heart failure symptoms. - Bronchospasm in patients with reactive airway disease.

Before initiating Nebivolol therapy, clinicians should consider several safety aspects.

- Blood pressure monitoring: ensure adequate control and avoid excessive drops. - Cardiac assessment: evaluate heart rate and conduction abnormalities. - Asthma or chronic obstructive pulmonary disease: use with caution due to potential bronchoconstriction. - Abrupt discontinuation: taper gradually to prevent rebound hypertension. - Renal impairment: dose adjustment may be required in severe dysfunction. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Nebivolol can interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - Combined use with other beta‑blockers: may cause excessive bradycardia or hypotension. - Calcium‑channel blockers verapamil or diltiazem: increase plasma levels and risk of cardiac depression. - Strong CYP2D6 inhibitors (e.g., paroxetine, fluoxetine): raise Nebivolol concentrations, enhancing adverse effects.

Moderate Interactions (Monitor Closely):\n- NSAIDs: may blunt antihypertensive response. - Diuretics: can potentiate hypotensive effects. - ACE inhibitors or ARBs: monitor for additive blood pressure lowering. - Antiarrhythmic agents (e.g., amiodarone): watch for conduction disturbances. - Antidiabetic drugs: monitor glucose control as blood pressure changes may affect glycemia.